V009-2129 Screening compound: 2-(4-FLUOROPHENYL)-1-[4-({5-[3-(TRIFLUOROMETHYL)PHENYL]-1,2,4-OXADIAZOL-3-YL}METHYL)PIPERAZINO]-1-ETHANONE

V009-2129 Screening compound: 2-(4-FLUOROPHENYL)-1-[4-({5-[3-(TRIFLUOROMETHYL)PHENYL]-1,2,4-OXADIAZOL-3-YL}METHYL)PIPERAZINO]-1-ETHANONE
V009-2129 Screening compound: 2-(4-FLUOROPHENYL)-1-[4-({5-[3-(TRIFLUOROMETHYL)PHENYL]-1,2,4-OXADIAZOL-3-YL}METHYL)PIPERAZINO]-1-ETHANONE alternative view

Chemical Structure Depiction of ChemDiv screening compound V009-2129
2-(4-FLUOROPHENYL)-1-[4-({5-[3-(TRIFLUOROMETHYL)PHENYL]-1,2,4-OXADIAZOL-3-YL}METHYL)PIPERAZINO]-1-ETHANONE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V009-2129

Molecular Formula

C22H20F4N4O2 (C22 H20 F4 N4 O2)

Compound Name

2-(4-FLUOROPHENYL)-1-[4-({5-[3-(TRIFLUOROMETHYL)PHENYL]-1,2,4-OXADIAZOL-3-YL}METHYL)PIPERAZINO]-1-ETHANONE

IUPAC name

n/a

SMILES

O=C(Cc(cc1)ccc1F)N1CCN(Cc2noc(-c3cc(C(F)(F)F)ccc3)n2)CC1

InChI

InChI=1S/C22H20F4N4O2/c23-18-6-4-15(5-7-18)12-20(31)30-10-8-29(9-11-30)14-19-27-21(32-28-19)16-2-1-3-17(13-16)22(24,25)26/h1-7,13H,8-12,14H2

InChI Key

PFJSMGVMYSAOAD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14286526

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

448.42

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.516

Distribution Coefficient, logD

3.516

Water Solubility, LogSw

-3.65

Polar Surface Area

52.568

Acid Dissociation Constant (pKa)

17.74

Base Dissociation Constant (pKb)

2.32

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.80

V009-2129 in Drug Discovery

Included in Screening Libraries

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
  • Ion Channels
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V009-2129 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V009-2129?
Check Price and Availability of V009-2129, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V009-2129 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V009-2129
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V009-2129
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V009-2129 available by request